Capstone Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-4,760
Closed -$228K 1613
2016
Q3
$228K Sell
4,760
-70
-1% -$3.46K 0.01% 1466
2016
Q2
$259K Buy
4,830
+150
+3% +$7.07K 0.01% 1375
2016
Q1
$209K Buy
+4,680
New +$190K 0.01% 1476
2015
Q4
Sell
-6,980
Closed -$222K 1598
2015
Q3
$222K Buy
6,980
+210
+3% +$7.32K 0.01% 1429
2015
Q2
$224K Sell
6,770
-3,720
-35% -$133K 0.01% 1463
2015
Q1
$432K Buy
10,490
+240
+2% +$9.7K 0.01% 1172
2014
Q4
$418K Sell
10,250
-920
-8% -$36K 0.01% 1155
2014
Q3
$409K Buy
11,170
+590
+6% +$25.5K 0.01% 1143
2014
Q2
$490K Buy
10,580
+1,139
+12% +$50.7K 0.02% 1082
2014
Q1
$388K Buy
9,441
+130
+1% +$4.83K 0.01% 1250
2013
Q4
$355K Buy
+9,311
New +$287K 0.01% 1392

Other funds holding ANIK